Bobo Donald E.'s most recent trade in Edwards Lifesciences Corp was a trade of 2,570 Common Stock done at an average price of $77.4 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 77.40 per share. | 02 Jun 2025 | 2,570 | 50,356 (0%) | 0% | 77.4 | 198,911 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.68 per share. | 11 May 2025 | 816 | 52,926 (0%) | 0% | 73.7 | 60,123 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 47,000 | 47,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 8,375 | 53,742 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 8,375 | 8,375 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.92 per share. | 07 May 2025 | 851 | 45,367 (0%) | 0% | 74.9 | 63,757 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share. | 03 May 2025 | 508 | 46,218 (0%) | 0% | 75.6 | 38,430 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share. | 03 May 2025 | 480 | 46,726 (0%) | 0% | 75.7 | 36,312 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Apr 2025 | 9,500 | 56,706 (0%) | 0% | 45.3 | 430,129 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 9,500 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 69.81 per share. | 14 Apr 2025 | 9,500 | 47,206 (0%) | 0% | 69.8 | 663,196 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 9,500 | 9,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 67.96 per share. | 13 Mar 2025 | 9,500 | 46,935 (0%) | 0% | 68.0 | 645,624 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Mar 2025 | 9,500 | 56,435 (0%) | 0% | 45.3 | 430,129 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Feb 2025 | 6,500 | 53,435 (0%) | 0% | 45.3 | 294,299 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,500 | 19,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 75.74 per share. | 13 Feb 2025 | 6,400 | 46,935 (0%) | 0% | 75.7 | 484,737 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 76.26 per share. | 13 Feb 2025 | 100 | 53,335 (0%) | 0% | 76.3 | 7,626 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 16 Jan 2025 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 68.75 per share. | 16 Jan 2025 | 5,000 | 46,935 (0%) | 0% | 68.7 | 343,736 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 5,000 | 25,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 09 Dec 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 5,000 | 30,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 71.75 per share. | 09 Dec 2024 | 5,000 | 46,935 (0%) | 0% | 71.8 | 358,751 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Nov 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 65.57 per share. | 13 Nov 2024 | 5,000 | 46,935 (0%) | 0% | 65.6 | 327,843 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2024 | 5,000 | 35,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 15 Oct 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 69.51 per share. | 15 Oct 2024 | 5,000 | 46,935 (0%) | 0% | 69.5 | 347,534 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 5,000 | 40,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 11 Sep 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 5,000 | 45,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 66.77 per share. | 11 Sep 2024 | 5,000 | 46,935 (0%) | 0% | 66.8 | 333,826 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Aug 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 5,000 | 50,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 66.08 per share. | 14 Aug 2024 | 5,000 | 46,935 (0%) | 0% | 66.1 | 330,420 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 Jul 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2024 | 5,000 | 55,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 93.29 per share. | 10 Jul 2024 | 5,000 | 46,935 (0%) | 0% | 93.3 | 466,474 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 87.54 per share. | 12 Jun 2024 | 5,000 | 46,935 (0%) | 0% | 87.5 | 437,697 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 5,000 | 60,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 12 Jun 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 87.81 per share. | 10 May 2024 | 5,000 | 47,749 (0%) | 0% | 87.8 | 439,038 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 5,000 | 65,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 May 2024 | 5,000 | 52,749 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 10 May 2024 | 814 | 46,935 (0%) | 0% | 86.7 | 70,590 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 39,600 | 39,600 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 6,700 | 48,368 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 6,700 | 6,700 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 619 | 47,749 (0%) | 0% | 85.1 | 52,671 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,855 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,855 | 45,143 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,475 | 41,668 (0%) | 0% | 85.3 | 296,244 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 479 | 39,288 (0%) | 0% | 85.1 | 40,744 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 08 Apr 2024 | 12,500 | 52,267 (0%) | 0% | 36.8 | 459,375 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 12,500 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 92.33 per share. | 08 Apr 2024 | 12,400 | 39,767 (0%) | 0% | 92.3 | 1,144,876 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 92.66 per share. | 08 Apr 2024 | 100 | 52,167 (0%) | 0% | 92.7 | 9,266 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Mar 2024 | 14,500 | 54,002 (0%) | 0% | 36.8 | 532,875 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 14,500 | 12,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 91.01 per share. | 13 Mar 2024 | 14,500 | 39,502 (0%) | 0% | 91.0 | 1,319,696 | Common Stock |
| Edwards Lifesciences Corp | Bobo Donald E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Feb 2024 | 11,000 | 50,502 (0%) | 0% | 36.8 | 404,250 | Common Stock |
| Edwards Lifesciences Corp | Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 11,000 | 27,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 85.81 per share. | 13 Feb 2024 | 10,530 | 39,502 (0%) | 0% | 85.8 | 903,573 | Common Stock |
| Edwards Lifesciences Corp | E. Bobo Donald | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 86.34 per share. | 13 Feb 2024 | 470 | 50,032 (0%) | 0% | 86.3 | 40,582 | Common Stock |
| Edwards Lifesciences Corp | Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 10,000 | 38,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 12 Jan 2024 | 10,000 | 49,502 (0%) | 0% | 36.8 | 367,500 | Common Stock |
| Edwards Lifesciences Corp | E. Donald Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 75.67 per share. | 12 Jan 2024 | 10,000 | 39,502 (0%) | 0% | 75.7 | 756,700 | Common Stock |
| Edwards Lifesciences Corp | Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 8,000 | 48,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bobo Donald E. | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 71.86 per share. | 13 Dec 2023 | 8,000 | 39,502 (0%) | 0% | 71.9 | 574,880 | Common Stock |
| Edwards Lifesciences Corp | Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Dec 2023 | 8,000 | 47,502 (0%) | 0% | 36.8 | 294,000 | Common Stock |
| Edwards Lifesciences Corp | Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 6,000 | 56,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Nov 2023 | 6,000 | 45,502 (0%) | 0% | 36.8 | 220,500 | Common Stock |
| Edwards Lifesciences Corp | Bobo E. Donald | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 65.66 per share. | 13 Nov 2023 | 3,700 | 39,502 (0%) | 0% | 65.7 | 242,929 | Common Stock |
| Edwards Lifesciences Corp | E. Bobo Donald | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 64.72 per share. | 13 Nov 2023 | 2,300 | 43,202 (0%) | 0% | 64.7 | 148,851 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Oct 2023 | 5,000 | 44,502 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2023 | 5,000 | 62,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 70.25 per share. | 13 Oct 2023 | 3,000 | 39,502 (0%) | 0% | 70.3 | 210,754 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 13 Oct 2023 | 2,000 | 42,502 (0%) | 0% | 69.6 | 139,156 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 4,500 | 67,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Sep 2023 | 4,500 | 44,002 (0%) | 0% | 36.8 | 165,375 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 73.71 per share. | 14 Sep 2023 | 4,500 | 39,502 (0%) | 0% | 73.7 | 331,695 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 79.30 per share. | 14 Aug 2023 | 4,500 | 39,502 (0%) | 0% | 79.3 | 356,850 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 4,500 | 71,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Aug 2023 | 4,500 | 44,002 (0%) | 0% | 36.8 | 165,375 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Jul 2023 | 3,500 | 43,002 (0%) | 0% | 36.8 | 128,625 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 3,500 | 76,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 92.94 per share. | 14 Jul 2023 | 3,500 | 39,502 (0%) | 0% | 92.9 | 325,275 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 3,500 | 79,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Jun 2023 | 3,500 | 43,002 (0%) | 0% | 36.8 | 128,625 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 89.77 per share. | 14 Jun 2023 | 3,500 | 39,502 (0%) | 0% | 89.8 | 314,195 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 54,200 | 54,200 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 8,025 | 8,025 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,425 | 39,502 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 89.22 per share. | 10 May 2023 | 2,500 | 33,077 (0%) | 0% | 89.2 | 223,050 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 10 May 2023 | 2,500 | 35,577 (0%) | 0% | 36.8 | 91,875 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2023 | 2,500 | 83,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 88.63 per share. | 05 May 2023 | 5,635 | 56,224 (0%) | 0% | 88.6 | 499,402 | Common Stock |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2023 | 4,767 | 60,991 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2023 | 4,767 | 1,308 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 05 May 2023 | 2,968 | 58,023 (0%) | 0% | 88.7 | 263,380 | Common Stock |